|
Monday 5th November 2018 |
Text too small? |
Orion Health Group has raised the minimum price it expects for its coming share buyback by about 3 percent.
The buyback, part of the firm’s recent restructuring, will likely be priced at $1.20 to $1.25 a share, the health technology company said today.
The lift, from the previously indicated range of $1.16 to $1.26 a share, reflects a better understanding of expected cash holdings with the completion of the sale to Hg last week, the firm said.
The buyback, expected later this month, follows the company’s decision to sell its Rhapsody unit to UK private equity firm Hg for $205 million, dilute its stake in its population health management unit, and retain full ownership of its hospitals division.
After capitalising the firm’s joint investments, the remainder of sale proceeds were to be allocated for the buyback.
Shareholders approved the transactions in late September.
(BusinessDesk)
No comments yet
PYS - PaySauce to announce F26 full year results on 27 May 2026
PEB - Draft LCD Proposes Medicare Coverage for Triage and Triage
MEL - Meridian Energy monthly operating report for April 2026
FBU - Sale of South Australian property
AIR - Air New Zealand market update
May 14th Morning Report
PEB - Pacific Edge Placement Increased to NZ$25.4 Million
Radius Care Reports Earnings Growth and 50% Higher Dividend
May 13th Morning Report
Pacific Edge launches capital raise of NZ$24 million